Observational studyPsychiatry and clinical neurosciences2026
Network-level disconnectivity tracks poststroke depressive symptom improvement.
Observational study in Psychiatry and clinical neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00887328 (Extending the Time for Thrombolysis in Emergency Neurological Deficits), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Extending the Time for Thrombolysis in Emergency Neurological Deficits
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
aimsPoststroke depression is the most common psychological condition following a stroke and can severely impact outcome. However, the neurobiological biomarkers associated with recovery of poststroke depression remain unclear. In this longitudinal observational study, we set out to investigate the effect of lesion-induced focal damage and network-level disconnectivity, and longitudinal structural connectivity on poststroke depression and its recovery.
methodsSixty-two participants underwent a psychological assessment utilizing the Montgomery-Asberg Depression Rating Scale (MADRS-SIGMA) at 3 and 12 months post first-ever stroke. First, we evaluated the relationship between lesions and MADRS scores at the 3 months using voxel-based lesion-symptom mapping and lesion network mapping. Next, we assessed the longitudinal relationship between structural connectivity and MADRS scores (change from 3 to 12 months) using multi-shell diffusion-weighted MRI data (n = 29) collected at both timepoints.
resultsPatient lesions mapped to a connected brain network centered on the left dorsolateral prefrontal cortex (P
conclusionsDepressive symptoms and their improvement mapped to a specific structural brain network. Knowledge of the integrity of this network could prove useful for predicting poststroke depression. CLINICAL
trial registrationSTART-PrePARE Australian New Zealand Clinical Trials, www.anzctr.org.au, Registry number: ACTRN12610000987066. EXTEND ClinicalTrial.gov identifier: NCT00887328.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.